Proteolytic activity and cytokine up-regulation by non-albicans Candida albicans

被引:6
|
作者
Nawaz, Ali [1 ,2 ]
Parnanen, Pirjo [1 ,2 ]
Kari, Kirsti [1 ,2 ]
Meurman, Jukka H. [1 ,2 ]
机构
[1] Univ Helsinki, Inst Dent, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Dept Oral & Maxillofacial Dis, Cent Hosp, Helsinki, Finland
关键词
Non-albicans Candida albicans; Proteolysis; Saliva; Cytokine expression; INVASIVE CANDIDIASIS; EPITHELIAL-CELLS; EPIDEMIOLOGY; MULTICENTER; INFECTIONS; GLABRATA; YEASTS; SALIVA; ALPHA; IL-8;
D O I
10.1007/s00203-015-1083-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mouth is an important source of infections and oral infections such as Candida infections increase the risk of mortality. Our purpose was to investigate differences in proteolytic activity of non-albicans Candida albicans (non-albicans Candida) between clinical isolates and laboratory samples. The second aim was to assess the concentration of pro- and anti-inflammatory cytokine levels IL-1 beta, IL-10, and TNF-alpha in saliva of patients with the non-albicans Candida and Candida-negative saliva samples. Clinical yeast samples from our laboratory were used for analyses. Candida strains were grown in YPG at 37 A degrees C for 24 h in water bath with shaking. The activity of Candida proteinases of cell and cell-free fractions were analyzed by MDPF-gelatin zymography. The levels of IL-1 beta, IL-10, and TNF-alpha were measured from saliva with ELISA. The study showed differences in the proteolytic activity among the non-albicans Candida strains. C. tropicalis had higher proteolytic activity when compared to the other strains. Significant difference was found in salivary IL-1 beta levels between the non-albicans Candida and control strains (P < 0.002). The present findings showed differences in proteolytic activity among the non-albicans Candida strains. The increased IL-1 beta concentration may be one of the host response components associated with non-albicans Candida infection.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 50 条
  • [31] Factors and outcomes associated with candidemia caused by non-albicans Candida spp versus Candida albicans in children
    Lee, Wei-Ju
    Hsu, Jen-Fu
    Lai, Mei-Yin
    Chiang, Ming-Chou
    Lin, Han-Chen
    Huang, Hsuan-Rong
    Wu, I-Hsyuan
    Chu, Shih-Ming
    Fu, Ren-Huei
    Tsai, Ming-Horng
    AMERICAN JOURNAL OF INFECTION CONTROL, 2018, 46 (12) : 1387 - 1393
  • [32] Risk factors and outcomes of Candida albicans and non-albicans Candida species at a Thai tertiary care center
    Apisarnthanarak, Anucha
    Naknarongkij, Nanta
    Kiratisin, Pattarachai
    Mundy, Linda M.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2009, 37 (09) : 781 - 782
  • [33] In vitro activity of terbinafine against Indian clinical isolates of Candida albicans and non-albicans using a macrodilution method
    Garg, S.
    Naidu, J.
    Singh, S. M.
    Nawange, S. R.
    Jharia, N.
    Saxena, M.
    JOURNAL DE MYCOLOGIE MEDICALE, 2006, 16 (03): : 119 - 125
  • [34] In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions
    Thein, Zaw M.
    Samaranayake, Yuthika H.
    Samaranayake, Lakshman P.
    ARCHIVES OF ORAL BIOLOGY, 2007, 52 (08) : 761 - 767
  • [35] Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection
    Katsumi Shigemura
    Kayo Osawa
    Takumi Jikimoto
    Hiroyuki Yoshida
    Brian Hayama
    Goh Ohji
    Kentaro Iwata
    Masato Fujisawa
    Soichi Arakawa
    The Journal of Antibiotics, 2014, 67 : 311 - 314
  • [36] An Update on the Roles of Non-albicans Candida Species in Vulvovaginitis
    Makanjuola, Olufunmilola
    Bongomin, Felix
    Fayemiwo, Samuel A.
    JOURNAL OF FUNGI, 2018, 4 (04)
  • [37] Antifungal activity of histatin-5 against non-albicans Candida species
    Nikawa, H
    Jin, C
    Fukushima, H
    Makihira, S
    Hamada, T
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2001, 16 (04): : 250 - 252
  • [38] Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome
    Chi, Hung-Wei
    Yang, Ya-Sung
    Shang, Shi-Ta
    Chen, Ke-Hung
    Yeh, Kuo-Ming
    Chang, Feng-Yee
    Lin, Jung-Chung
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2011, 44 (05) : 369 - 375
  • [39] Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species
    Bellavita, Rosa
    Maione, Angela
    Merlino, Francesco
    Siciliano, Antonietta
    Dardano, Principia
    De Stefano, Luca
    Galdiero, Stefania
    Galdiero, Emilia
    Grieco, Paolo
    Falanga, Annarita
    PHARMACEUTICS, 2022, 14 (02)
  • [40] Marine bacterial DNase curtails virulence and disrupts biofilms of Candida albicans and non-albicans Candida species
    Banu, Sanaulla Farisa
    Thamotharan, Subbiah
    Gowrishankar, Shanmugaraj
    Pandian, Shunmugiah Karutha
    Nithyanand, Paramasivam
    BIOFOULING, 2019, 35 (09) : 975 - 985